Celerion specializes in early development and clinical pharmacology solutions that accelerate time to market and empower clients with the information needed to make informed decisions earlier in the drug development process. A global CRO with locations across North America and Europe, it provides global clinical research and development, data management and biometrics, global bioanalytical services and drug development services for clients around the world. With a large clinical capacity of more than 600 beds, efficient bioanalytical laboratories and experienced scientific staff, Celerion offers one of the most experienced clinical pharmacology research networks in the industry.